Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand nam… Read more
Reckitt Benckiser Group PLC (RBGPF) - Net Assets
Latest net assets as of June 2025: $6.35 Billion USD
Based on the latest financial reports, Reckitt Benckiser Group PLC (RBGPF) has net assets worth $6.35 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($24.62 Billion) and total liabilities ($18.27 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.35 Billion |
| % of Total Assets | 25.79% |
| Annual Growth Rate | 8.11% |
| 5-Year Change | -26.63% |
| 10-Year Change | -2.69% |
| Growth Volatility | 20.86 |
Reckitt Benckiser Group PLC - Net Assets Trend (2002–2024)
This chart illustrates how Reckitt Benckiser Group PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Reckitt Benckiser Group PLC (2002–2024)
The table below shows the annual net assets of Reckitt Benckiser Group PLC from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.72 Billion | -20.65% |
| 2023-12-31 | $8.47 Billion | -10.69% |
| 2022-12-31 | $9.48 Billion | +27.24% |
| 2021-12-31 | $7.45 Billion | -18.63% |
| 2020-12-31 | $9.16 Billion | -2.64% |
| 2019-12-31 | $9.41 Billion | -36.39% |
| 2018-12-31 | $14.79 Billion | +8.96% |
| 2017-12-31 | $13.57 Billion | +61.08% |
| 2016-12-31 | $8.43 Billion | +22.01% |
| 2015-12-31 | $6.91 Billion | +1.05% |
| 2014-12-31 | $6.83 Billion | +7.86% |
| 2013-12-31 | $6.34 Billion | +6.99% |
| 2012-12-31 | $5.92 Billion | +2.44% |
| 2011-12-31 | $5.78 Billion | +12.69% |
| 2010-12-31 | $5.13 Billion | +27.80% |
| 2009-12-31 | $4.01 Billion | +21.86% |
| 2008-12-31 | $3.29 Billion | +38.11% |
| 2007-12-31 | $2.38 Billion | +27.81% |
| 2006-12-31 | $1.87 Billion | +0.54% |
| 2005-12-31 | $1.86 Billion | +17.47% |
| 2004-12-31 | $1.58 Billion | +7.19% |
| 2003-12-31 | $1.47 Billion | +22.02% |
| 2002-12-31 | $1.21 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Reckitt Benckiser Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2704.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $21.99 Billion | 328.26% |
| Common Stock | $74.00 Million | 1.10% |
| Total Equity | $6.70 Billion | 100.00% |
Reckitt Benckiser Group PLC Competitors by Market Cap
The table below lists competitors of Reckitt Benckiser Group PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Teradyne Inc
NASDAQ:TER
|
$46.73 Billion |
|
Targa Resources Inc
NYSE:TRGP
|
$46.85 Billion |
|
BASF SE NA O.N.
OTCQX:BFFAF
|
$47.09 Billion |
|
Comfort Systems USA Inc
NYSE:FIX
|
$47.20 Billion |
|
Kroger Company
NYSE:KR
|
$46.45 Billion |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
$46.38 Billion |
|
WW Grainger Inc
NYSE:GWW
|
$46.36 Billion |
|
Ford Motor Company
NYSE:F
|
$46.29 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Reckitt Benckiser Group PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,448,000,000 to 6,699,000,000, a change of -1,749,000,000 (-20.7%).
- Net income of 1,426,000,000 contributed positively to equity growth.
- Dividend payments of 1,381,000,000 reduced retained earnings.
- Share repurchases of 1,328,000,000 reduced equity.
- Other comprehensive income increased equity by 15,289,000,000.
- Other factors decreased equity by 15,755,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.43 Billion | +21.29% |
| Dividends Paid | $1.38 Billion | -20.62% |
| Share Repurchases | $1.33 Billion | -19.82% |
| Other Comprehensive Income | $15.29 Billion | +228.23% |
| Other Changes | $-15.76 Billion | -235.18% |
| Total Change | $- | -20.70% |
Book Value vs Market Value Analysis
This analysis compares Reckitt Benckiser Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43.66x to 7.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $1.58 | $69.02 | x |
| 2003-12-31 | $1.94 | $69.02 | x |
| 2004-12-31 | $2.09 | $69.02 | x |
| 2005-12-31 | $2.50 | $69.02 | x |
| 2006-12-31 | $2.54 | $69.02 | x |
| 2007-12-31 | $3.25 | $69.02 | x |
| 2008-12-31 | $4.55 | $69.02 | x |
| 2009-12-31 | $5.51 | $69.02 | x |
| 2010-12-31 | $6.90 | $69.02 | x |
| 2011-12-31 | $7.76 | $69.02 | x |
| 2012-12-31 | $8.08 | $69.02 | x |
| 2013-12-31 | $8.69 | $69.02 | x |
| 2014-12-31 | $9.35 | $69.02 | x |
| 2015-12-31 | $9.54 | $69.02 | x |
| 2016-12-31 | $11.79 | $69.02 | x |
| 2017-12-31 | $19.03 | $69.02 | x |
| 2018-12-31 | $20.79 | $69.02 | x |
| 2019-12-31 | $13.21 | $69.02 | x |
| 2020-12-31 | $12.77 | $69.02 | x |
| 2021-12-31 | $10.37 | $69.02 | x |
| 2022-12-31 | $13.16 | $69.02 | x |
| 2023-12-31 | $11.76 | $69.02 | x |
| 2024-12-31 | $9.44 | $69.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Reckitt Benckiser Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.29%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.06%
- • Asset Turnover: 0.56x
- • Equity Multiplier: 3.78x
- Recent ROE (21.29%) is below the historical average (26.41%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 34.11% | 11.81% | 0.98x | 2.94x | $288.40 Million |
| 2003 | 33.27% | 13.17% | 0.97x | 2.60x | $342.00 Million |
| 2004 | 36.59% | 14.91% | 1.00x | 2.44x | $419.30 Million |
| 2005 | 36.06% | 16.01% | 0.99x | 2.27x | $483.50 Million |
| 2006 | 36.18% | 13.69% | 0.86x | 3.08x | $487.70 Million |
| 2007 | 39.36% | 17.80% | 0.90x | 2.46x | $699.70 Million |
| 2008 | 34.02% | 17.07% | 0.71x | 2.79x | $790.80 Million |
| 2009 | 35.34% | 18.29% | 0.90x | 2.16x | $1.02 Billion |
| 2010 | 31.00% | 18.55% | 0.63x | 2.65x | $1.06 Billion |
| 2011 | 30.56% | 18.40% | 0.67x | 2.47x | $1.17 Billion |
| 2012 | 30.75% | 19.03% | 0.63x | 2.55x | $1.23 Billion |
| 2013 | 27.46% | 17.32% | 0.66x | 2.39x | $1.11 Billion |
| 2014 | 47.18% | 36.48% | 0.57x | 2.27x | $2.54 Billion |
| 2015 | 25.25% | 19.64% | 0.58x | 2.21x | $1.05 Billion |
| 2016 | 21.76% | 18.52% | 0.55x | 2.14x | $989.90 Million |
| 2017 | 45.61% | 53.61% | 0.31x | 2.74x | $4.82 Billion |
| 2018 | 14.65% | 17.14% | 0.33x | 2.55x | $684.80 Million |
| 2019 | -29.61% | -21.58% | 0.40x | 3.43x | $-3.71 Billion |
| 2020 | 13.02% | 8.48% | 0.45x | 3.43x | $275.50 Million |
| 2021 | -0.43% | -0.24% | 0.49x | 3.64x | $-771.90 Million |
| 2022 | 24.67% | 16.12% | 0.50x | 3.04x | $1.39 Billion |
| 2023 | 19.45% | 11.25% | 0.54x | 3.21x | $798.20 Million |
| 2024 | 21.29% | 10.06% | 0.56x | 3.78x | $756.10 Million |
Industry Comparison
This section compares Reckitt Benckiser Group PLC's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,833,853,398
- Average return on equity (ROE) among peers: 27.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Reckitt Benckiser Group PLC (RBGPF) | $6.35 Billion | 34.11% | 2.88x | $46.53 Billion |
| Acme United Corporation (ACU) | $19.90 Million | 2.51% | 0.55x | $132.86 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $3.02 Billion | 8.59% | 0.75x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.70 Billion | 16.88% | 0.41x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $12.35 Billion | 8.22% | 0.18x | $1.01 Billion |
| Bemax Inc (BMXC) | $-244.86K | 0.00% | 0.00x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.97 Million |
| Church & Dwight Company Inc (CHD) | $284.43 Million | 16.52% | 2.34x | $22.97 Billion |
| Colgate-Palmolive Company (CL) | $971.00 Million | 223.07% | 14.49x | $67.85 Billion |